The Epidemiology of Diabetes and Cancer
The Epidemiology of Diabetes and Cancer
复制标题
DOI：
10.1007/s11892-014-0535-8
复制
发表时间：
2014-10-01
影响因子：
4.2
通讯作者：
Friis, Soren
中科院分区：
文献类型：
--
作者：
Carstensen, Bendix;Jorgensen, Marit Eika;Friis, Soren
关于糖尿病患者癌症发生的文献几乎总是与相关措施有关。在本文中，我们简要回顾了这一点，但目的是量化人群中糖尿病和癌症的绝对发生率，以便更全面地了解情况，其中还包括竞争性死亡风险。总的来说，我们发现大约35%的人口在一生中会被诊断为糖尿病，44%的人被诊断为癌症，大约15%的人会同时被诊断为糖尿病和癌症。糖尿病患者和非糖尿病患者之间死亡率不同的影响可以通过以下事实来说明：50岁时没有糖尿病的人比50岁患有糖尿病的人一生中患癌症的风险更小。因此，糖尿病患者和非糖尿病患者之间癌症发生率的差异在数量上的重要性小于死亡率的差异。
The literature on cancer occurrence in persons with diabetes has almost invariably been concerned with relative measures. In this paper, we briefly review this, but the aim is to quantify the absolute occurrence of diabetes and cancer in the population in order to give a fuller picture, which also includes the competing mortality risk. Overall, we find that some 35 % of the population will have a diagnosis of diabetes in their lifetime, 44 % a diagnosis of cancer, and about 15 % will have both diagnoses. The impact of differing mortality between persons with and without diabetes is illustrated by the fact that a person without diabetes at age 50 has a smaller lifetime risk of cancer than a person aged 50 with diabetes. Thus, the differences in cancer occurrence between persons with and without diabetes are of quantitatively smaller importance than the differences in mortality.